Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06281145

Stress-Reducing Intervention in Patients With Colorectal and Breast Cancer

A Study on Therapeutic Potential of Stress-Reducing Intervention in Patients With Solid Tumors

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Comenius University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this interventional study is to test the heart-rate variability biofeedback intervention (HRV BI) in 2 cohorts of patients. Cohort A will evaluate the effect of the addition of HRV BI in patients with breast cancer treated in the neoadjuvant setting (vs. standard of care alone, SOC) followed by local therapy (surgery +/-radiotherapy). Cohort B will evaluate the effect of the addition of HRV BI in patients with colon cancer after surgery in the adjuvant setting (vs. standard of care alone, SOC).

Detailed description

This is a prospective, interventional, clinical study with in 2 cohorts. Target of subjects is 50 per cohort and an anticipated total duration of 36 months. Participants will undergo 4 sessions of HRV BI with the trainer where they will learn about the prognostic role of the vagal nerve in cancer and in reducing distress and pain, and how to perform deep paced breathing with the HRV monitoring. They will perform the training daily (3-times, minimum 7 minutes each) at home with the online control for 3 months. Researchers will compare the effect of addition of 3-months training of HRV BI to SOC on inflammation, HRV, quality of life (QoL), cognitive functions, salivary cortisol slopes, sleep quality and treatment outcomes of patients with colorectal and breast cancer.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHeart-rate variability biofeedback interventionDaily deep paced breathing 3-times (minimum 7 minutes each) for 3 months

Timeline

Start date
2024-03-15
Primary completion
2027-03-15
Completion
2029-03-15
First posted
2024-02-28
Last updated
2024-02-28

Locations

1 site across 1 country: Slovakia

Source: ClinicalTrials.gov record NCT06281145. Inclusion in this directory is not an endorsement.